David Hymel

558 total citations
25 papers, 420 citations indexed

About

David Hymel is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, David Hymel has authored 25 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in David Hymel's work include Click Chemistry and Applications (8 papers), Chemical Synthesis and Analysis (6 papers) and Ubiquitin and proteasome pathways (6 papers). David Hymel is often cited by papers focused on Click Chemistry and Applications (8 papers), Chemical Synthesis and Analysis (6 papers) and Ubiquitin and proteasome pathways (6 papers). David Hymel collaborates with scholars based in United States, Japan and Denmark. David Hymel's co-authors include Terrence R. Burke, Blake R. Peterson, Christoph Rader, Xue Zhi Zhao, Kohei Tsuji, Xiuling Li, Even Walseng, William Roush, Fa Liu and Junpeng Qi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

David Hymel

25 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hymel United States 11 263 185 108 106 60 25 420
Lukas Deweid Germany 11 251 1.0× 101 0.5× 158 1.5× 84 0.8× 40 0.7× 17 375
Péter A. Szijj United Kingdom 11 272 1.0× 145 0.8× 186 1.7× 219 2.1× 37 0.6× 14 448
Adam D. Cotton United States 5 505 1.9× 284 1.5× 75 0.7× 38 0.4× 26 0.4× 6 605
Josef A. Gramespacher United States 8 587 2.2× 283 1.5× 105 1.0× 47 0.4× 26 0.4× 8 692
Paul C. Klauser United States 9 331 1.3× 86 0.5× 117 1.1× 213 2.0× 33 0.6× 11 462
Eline Sijbesma Netherlands 14 700 2.7× 94 0.5× 63 0.6× 93 0.9× 28 0.5× 18 841
Christopher T. Saeui United States 14 379 1.4× 65 0.4× 109 1.0× 116 1.1× 59 1.0× 25 507
Johannes T.‐H. Yeh United States 8 529 2.0× 101 0.5× 113 1.0× 163 1.5× 19 0.3× 13 586
Erik D. Wold United States 8 351 1.3× 158 0.9× 226 2.1× 155 1.5× 40 0.7× 10 498

Countries citing papers authored by David Hymel

Since Specialization
Citations

This map shows the geographic impact of David Hymel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hymel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hymel more than expected).

Fields of papers citing papers by David Hymel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hymel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hymel. The network helps show where David Hymel may publish in the future.

Co-authorship network of co-authors of David Hymel

This figure shows the co-authorship network connecting the top 25 collaborators of David Hymel. A scholar is included among the top collaborators of David Hymel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hymel. David Hymel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hymel, David, Felix Wojcik, Wouter F. J. Hogendorf, et al.. (2024). Photochemically-enabled, post-translational production of C-terminal amides. Nature Communications. 15(1). 7162–7162. 3 indexed citations
2.
Tsuji, Kohei, David Hymel, Buyong Ma, et al.. (2022). Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1. RSC Chemical Biology. 3(9). 1111–1120. 8 indexed citations
3.
Mehrotra, Suneet, Elizabeth M. Glenn, David Hymel, et al.. (2022). Unanticipated Characteristics of a Selective, Potent Neuromedin-U Receptor 2 Agonist. SHILAP Revista de lepidopterología. 2(4). 370–375. 2 indexed citations
4.
5.
Tsuji, Kohei, David Hymel, & Terrence R. Burke. (2020). A new genre of fluorescence recovery assay to evaluate polo-like kinase 1 ATP-competitive inhibitors. Analytical Methods. 12(36). 4418–4421. 3 indexed citations
6.
Hymel, David & Fa Liu. (2020). Selective Lysine Modification Enabled by Intramolecular Acyl Transfer. Organic Letters. 22(8). 3067–3071. 5 indexed citations
7.
Qi, Junpeng, Kohei Tsuji, David Hymel, et al.. (2020). Chemically Programmable and Switchable CAR‐T Therapy. Angewandte Chemie. 132(29). 12276–12283. 6 indexed citations
8.
Hymel, David, et al.. (2020). Further Exploration of Hydrazine-Mediated Bioconjugation Chemistries. Organic Letters. 22(16). 6677–6681. 7 indexed citations
9.
Hymel, David & Fa Liu. (2020). Proximity‐driven, Regioselective Chemical Modification of Peptides and Proteins. Asian Journal of Organic Chemistry. 10(1). 38–49. 6 indexed citations
10.
Qi, Junpeng, et al.. (2019). Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1. Frontiers in Immunology. 10. 1994–1994. 7 indexed citations
11.
Zhao, Xue Zhi, Kohei Tsuji, David Hymel, & Terrence R. Burke. (2019). Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors. Molecules. 24(8). 1488–1488. 7 indexed citations
12.
Hymel, David, et al.. (2019). Antibody–Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome–Disruptive Peptide. ACS Omega. 4(7). 12955–12968. 10 indexed citations
13.
Hymel, David, Robert A. Grant, Kohei Tsuji, Michael B. Yaffe, & Terrence R. Burke. (2018). Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(19). 3202–3205. 13 indexed citations
14.
Li, Xiuling, Lori Hazlehurst, Pablo Martínez-Acedo, et al.. (2017). Stable and Potent Selenomab-Drug Conjugates. Cell chemical biology. 24(4). 433–442.e6. 33 indexed citations
15.
Lu, Xiuxiu, Urszula Nowicka, Fen Liu, et al.. (2017). Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets. Nature Communications. 8(1). 15540–15540. 61 indexed citations
16.
Li, Xiuling, Even Walseng, David Hymel, et al.. (2017). Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates. Nature Communications. 8(1). 1112–1112. 78 indexed citations
17.
Zhao, Xue Zhi, David Hymel, & Terrence R. Burke. (2017). Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides. Bioorganic & Medicinal Chemistry. 25(19). 5041–5049. 15 indexed citations
18.
Zhao, Xue Zhi, David Hymel, & Terrence R. Burke. (2016). Application of oxime-diversification to optimize ligand interactions within a cryptic pocket of the polo-like kinase 1 polo-box domain. Bioorganic & Medicinal Chemistry Letters. 26(20). 5009–5012. 17 indexed citations
19.
Hymel, David, et al.. (2014). Detection of Protein–Protein Interactions by Proximity-Driven SNAr Reactions of Lysine-Linked Fluorophores. Journal of the American Chemical Society. 136(14). 5241–5244. 14 indexed citations
20.
Hymel, David & Blake R. Peterson. (2012). Synthetic cell surface receptors for delivery of therapeutics and probes. Advanced Drug Delivery Reviews. 64(9). 797–810. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lukas Deweid Breakdown of academic impact, for papers by Péter A. Szijj Breakdown of academic impact, for papers by Adam D. Cotton Breakdown of academic impact, for papers by Josef A. Gramespacher Breakdown of academic impact, for papers by Paul C. Klauser Breakdown of academic impact, for papers by Eline Sijbesma Breakdown of academic impact, for papers by Christopher T. Saeui Breakdown of academic impact, for papers by Johannes T.‐H. Yeh Breakdown of academic impact, for papers by Erik D. Wold
Rankless by CCL
2026